Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maccario

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
European Journal of Endocrinology|August 1, 1996
Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesityM Maccario, S Grottoli, P Razzore, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|September 21, 2000
The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factorsM Maccario, S Grottoli, M Procopio, et al.
Journal of Endocrinological Investigation|June 20, 1998
Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertensionM Maccario, S E Oleandri, E Avogadri, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesityM Maccario, F Tassone, L Gianotti, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humansE Arvat, B Maccagno, R Giordano, et al.
Pituitary|June 1, 2001
Glucagon is an ACTH secretagogue as effective as hCRH after intramuscolar administration while it is ineffective when given intravenously in normal subjectsE Arvat, B Maccagno, J Ramunni, et al.
Clinical Endocrinology|December 18, 2003
Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph functionF Lanfranco, L Gianotti, S Pivetti, et al.
The American Journal of Physiology|June 11, 1999
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and womenE Ghigo, G Aimaretti, M Maccario, et al.
Journal of Endocrinological Investigation|January 1, 1997
Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesityM Maccario, S Grottoli, M Procopio, et al.
Pituitary|November 18, 2000
Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's diseaseS Grottoli, E Arvat, C Gauna, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
European Journal of Endocrinology|August 1, 1996
Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesityM Maccario, S Grottoli, P Razzore, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|September 21, 2000
The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factorsM Maccario, S Grottoli, M Procopio, et al.
Journal of Endocrinological Investigation|June 20, 1998
Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertensionM Maccario, S E Oleandri, E Avogadri, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesityM Maccario, F Tassone, L Gianotti, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humansE Arvat, B Maccagno, R Giordano, et al.
Pituitary|June 1, 2001
Glucagon is an ACTH secretagogue as effective as hCRH after intramuscolar administration while it is ineffective when given intravenously in normal subjectsE Arvat, B Maccagno, J Ramunni, et al.
Clinical Endocrinology|December 18, 2003
Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph functionF Lanfranco, L Gianotti, S Pivetti, et al.
The American Journal of Physiology|June 11, 1999
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and womenE Ghigo, G Aimaretti, M Maccario, et al.
Journal of Endocrinological Investigation|January 1, 1997
Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesityM Maccario, S Grottoli, M Procopio, et al.
Pituitary|November 18, 2000
Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's diseaseS Grottoli, E Arvat, C Gauna, et al.
Pageof 16